Working… Menu

Evaluation of Superiority of Valsartan+Celecoxib+Metformin Over Metformin Alone in Type 2 Diabetes Patients (RESILIENCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03686657
Recruitment Status : Not yet recruiting
First Posted : September 27, 2018
Last Update Posted : October 9, 2019
Albany Medical College
Information provided by (Responsible Party):
ARKAY Therapeutics

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : November 30, 2021
Estimated Study Completion Date : January 31, 2022